FAQ

PNT2258

Known as: DNA Interference Oligonucleotide PNT2258 
A liposomal formulation of the 24-mer oligonucleotide PNT100, with potential antineoplastic activity. PNT2258 targets and complements to… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2016
01220132016

Related topics

Related topics

1 relation

Broader (1)

PNT100

Related mentions per year

Related mentions per year

2013-2017
201020122014201620182020
PNT2258
PNT100

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Unintended target effect of anti-BCL-2 DNAi
INTRODUCTION Previous research suggested that a novel compound PNT2258 inhibits B-cell lymphoma 2 (BCL-2) transcription by DNA… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2016
2016
PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma
Current therapy for BCL-2-associated tumors such as Non-Hodgkin Lymphomas (NHL) is inadequate. The DNAi PNT2258, a 24 base single… (More)
Is this relevant?
Review
2016
Review
2016
Hematologic malignancies: newer strategies to counter the BCL-2 protein
BCL-2 is the founding member of the BCL-2 family of apoptosis regulatory proteins that either induce (pro-apoptotic) or inhibit… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2014
2014
Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
PNT100 is a 24-base, chemically unmodified DNA oligonucleotide sequence that is complementary to a region upstream of the BCL-2… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Maximum tolerated dose, safety, pharmacokinetics, and pharmacodynamics were assessed in this phase 1 study of PNT2258, a BCL-2… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?